We are live on ! Find out more
FGP

Freestone Grove Partners Portfolio holdings

AUM $14.2B
1-Year Est. Return 24.58%
This Fund
S&P 500
This Quarter Est. Return
+3.03%
1 Year Est. Return
+24.58%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$13.8B
AUM Growth
+$442M
Cap. Flow
+$225M
Cap. Flow %
1.62%
Top 10 Hldgs %
20.13%
Holding
998
New
320
Increased
181
Reduced
201
Closed
285

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$767M
2
AMZN icon
Amazon
AMZN
+$156M
3
BSX icon
Boston Scientific
BSX
+$123M
4
LEN icon
Lennar Class A
LEN
+$113M
5
ELV icon
Elevance Health
ELV
+$95.7M

Top Sells

Rank Stock Value
1
CTAS icon
Cintas
CTAS
+$134M
2
NFLX icon
Netflix
NFLX
+$107M
3
PG icon
Procter & Gamble
PG
+$106M
4
MMM icon
3M
MMM
+$102M
5
ZBH icon
Zimmer Biomet
ZBH
+$91.2M

Sector Composition

Rank Sector Weight
1 Industrials 15.04%
2 Financials 14.57%
3 Technology 12.47%
4 Healthcare 12.2%
5 Consumer Discretionary 8.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GD icon
126
General Dynamics
GD
$103B
$34.8M 0.25%
103,272
-99,474
-49% -$33.9M
CNC icon
127
Centene
CNC
$31.5B
$34.7M 0.25%
842,863
-408,184
-33% -$15.3M
MKC icon
128
McCormick & Company Non-Voting
MKC
$13.5B
$34.4M 0.25%
+505,335
New +$33.6M
MCO icon
129
Moody's
MCO
$82.5B
$33.7M 0.24%
65,874
-23,544
-26% -$11.5M
BIO icon
130
Bio-Rad Laboratories Class A
BIO
$8.47B
$33.5M 0.24%
+110,524
New +$34.5M
GRMN
131
Garmin
GRMN
$46.3B
$33.4M 0.24%
164,463
+37,355
+29% +$8.12M
VNOM icon
132
Viper Energy
VNOM
$8.81B
$33.1M 0.24%
858,100
– –
BIIB icon
133
Biogen
BIIB
$29.6B
$33M 0.24%
187,608
-31,258
-14% -$5.11M
CME icon
134
CME Group
CME
$91.9B
$32.8M 0.24%
120,023
+72,593
+153% +$19.7M
AHR icon
135
American Healthcare REIT
AHR
$10.9B
$32.7M 0.24%
+694,952
New +$32.2M
OMF icon
136
OneMain Financial
OMF
$6.79B
$32.7M 0.24%
483,363
+129,895
+37% +$7.9M
PLMR icon
137
Palomar
PLMR
$3.42B
$32.5M 0.23%
240,887
+15,370
+7% +$1.88M
AFL icon
138
Aflac
AFL
$63.3B
$32.4M 0.23%
+294,119
New +$32.4M
CACI icon
139
CACI
CACI
$10.6B
$32.3M 0.23%
60,670
-6,707
-10% -$3.79M
BRKR icon
140
Bruker
BRKR
$9.46B
$32.3M 0.23%
685,927
+204,006
+42% +$8.62M
DY icon
141
Dycom Industries
DY
$13.2B
$32.2M 0.23%
95,211
-99,184
-51% -$31.3M
RH icon
142
RH
RH
$3.14B
$32.1M 0.23%
+179,198
New +$30.6M
FERG icon
143
Ferguson
FERG
$44.3B
$32.1M 0.23%
143,977
+142,157
+7,811% +$34M
REGN icon
144
Regeneron Pharmaceuticals
REGN
$68.3B
$32M 0.23%
41,409
-22,820
-36% -$15.5M
PH icon
145
Parker-Hannifin
PH
$124B
$31.9M 0.23%
36,260
-77,235
-68% -$63.2M
TNDM icon
146
Tandem Diabetes Care
TNDM
$1.16B
$31.7M 0.23%
1,442,836
-427,471
-23% -$7.71M
SLG icon
147
SL Green Realty
SLG
$3.81B
$31.5M 0.23%
686,552
+679,815
+10,091% +$33.6M
KEY icon
148
KeyCorp
KEY
$24.4B
$31.3M 0.23%
+1,517,838
New +$28.3M
ISRG icon
149
Intuitive Surgical
ISRG
$119B
$31.3M 0.23%
+55,188
New +$29.4M
WAY
150
Waystar Holding Corp
WAY
$4.14B
$30.9M 0.22%
944,380
-23,055
-2% -$821K
4 5
6
7 8

Similar funds

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $14.2B AUM 20.68% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
X
Xponance Philadelphia, Pennsylvania $14.1B AUM 30.11% 1-Year Est. Return
CM
Capula Management Grand Cayman, Cayman Islands $14.1B AUM 19.14% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Freestone Grove Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Freestone Grove Partners held 998 positions worth $13.8B, up 3.3% from $13.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Freestone Grove Partners's Q4 2025 filing shows 320 new, 181 increased, 201 reduced and 285 closed positions. Its largest new stake was Amazon: 683,670 shares worth $158M. The largest sale was Cintas, an estimated $134M.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, down from 17% a quarter earlier, followed by Financials and Technology.

  • Freestone Grove Partners's largest Q4 2025 buy was Amazon: 683,670 shares worth $158M.
  • Freestone Grove Partners added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $767M increase.
  • Freestone Grove Partners's biggest Q4 2025 reduction was Cintas, cutting an estimated $134M.
  • Freestone Grove Partners fully exited Netflix in Q4 2025, selling an estimated $107M.
  • Freestone Grove Partners's ten largest holdings make up 20% of its $13.8B portfolio in Q4 2025.
  • Freestone Grove Partners opened 320 new positions and closed 285 in Q4 2025.
  • Freestone Grove Partners's portfolio value rose 3.3% quarter-over-quarter to $13.8B.

Based on Freestone Grove Partners's 13F filing for Q4 2025, filed 17 Feb 2026.